The global Hemostats market was valued at US$ 2825 million in 2022 and is projected to reach US$ 4149.5 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Hemostats market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Hemostats market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Hemostats market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
This report aims to provide a comprehensive presentation of the global market for Hemostats, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostats. This report contains market size and forecasts of Hemostats in global, including the following market information:
- Global Hemostats Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Hemostats Market Sales, 2018-2023, 2024-2029, (K Pcs)
- Global top five Hemostats companies in 2022 (%)
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
We surveyed the Hemostats manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostats Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Hemostats Market Segment Percentages, by Type, 2022 (%)
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Global Hemostats Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Hemostats Market Segment Percentages, by Application, 2022 (%)
- Prehospital Treatment
- Hospital Treatment
Global Hemostats Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Hemostats Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hemostats revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Hemostats revenues share in global market, 2022 (%)
- Key companies Hemostats sales in global market, 2018-2023 (Estimated), (K Pcs)
- Key companies Hemostats sales share in global market, 2022 (%)
key players include:
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemostats, market overview.
Chapter 2: Global Hemostats market size in revenue and volume.
Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemostats in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hemostats capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
